Pharma & Healthcare
Edaravone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 549974
- Pages: 90
- Figures: 209
- Views: 4
The global market for Edaravone was estimated to be worth US$ 983.4 million in 2023 and is forecast to a readjusted size of US$ 1346.7 million by 2030 with a CAGR of 4.6% during the forecast period 2024-2030
North American market for Edaravone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Edaravone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Edaravone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Edaravone include Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd, UCB India Ltd and Piramal Healthcare, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Edaravone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Edaravone by region & country, by Type, and by Application.
The Edaravone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone.
Market Segmentation
By Company
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
Segment by Type:
Oral Edaravone
Injection Edaravone
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Edaravone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Edaravone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Edaravone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Edaravone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Edaravone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Edaravone include Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd, UCB India Ltd and Piramal Healthcare, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Edaravone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Edaravone by region & country, by Type, and by Application.
The Edaravone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone.
Market Segmentation
By Company
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
Segment by Type:
Oral Edaravone
Injection Edaravone
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Edaravone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Edaravone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Edaravone Product Introduction
1.2 Global Edaravone Market Size Forecast
1.2.1 Global Edaravone Sales Value (2019-2030)
1.2.2 Global Edaravone Sales Volume (2019-2030)
1.2.3 Global Edaravone Sales Price (2019-2030)
1.3 Edaravone Market Trends & Drivers
1.3.1 Edaravone Industry Trends
1.3.2 Edaravone Market Drivers & Opportunity
1.3.3 Edaravone Market Challenges
1.3.4 Edaravone Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Edaravone Players Revenue Ranking (2023)
2.2 Global Edaravone Revenue by Company (2019-2024)
2.3 Global Edaravone Players Sales Volume Ranking (2023)
2.4 Global Edaravone Sales Volume by Company Players (2019-2024)
2.5 Global Edaravone Average Price by Company (2019-2024)
2.6 Key Manufacturers Edaravone Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Edaravone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Edaravone
2.9 Edaravone Market Competitive Analysis
2.9.1 Edaravone Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Edaravone Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edaravone as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral Edaravone
3.1.2 Injection Edaravone
3.2 Global Edaravone Sales Value by Type
3.2.1 Global Edaravone Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Edaravone Sales Value, by Type (2019-2030)
3.2.3 Global Edaravone Sales Value, by Type (%) (2019-2030)
3.3 Global Edaravone Sales Volume by Type
3.3.1 Global Edaravone Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Edaravone Sales Volume, by Type (2019-2030)
3.3.3 Global Edaravone Sales Volume, by Type (%) (2019-2030)
3.4 Global Edaravone Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Edaravone Sales Value by Application
4.2.1 Global Edaravone Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Edaravone Sales Value, by Application (2019-2030)
4.2.3 Global Edaravone Sales Value, by Application (%) (2019-2030)
4.3 Global Edaravone Sales Volume by Application
4.3.1 Global Edaravone Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Edaravone Sales Volume, by Application (2019-2030)
4.3.3 Global Edaravone Sales Volume, by Application (%) (2019-2030)
4.4 Global Edaravone Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Edaravone Sales Value by Region
5.1.1 Global Edaravone Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Edaravone Sales Value by Region (2019-2024)
5.1.3 Global Edaravone Sales Value by Region (2025-2030)
5.1.4 Global Edaravone Sales Value by Region (%), (2019-2030)
5.2 Global Edaravone Sales Volume by Region
5.2.1 Global Edaravone Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Edaravone Sales Volume by Region (2019-2024)
5.2.3 Global Edaravone Sales Volume by Region (2025-2030)
5.2.4 Global Edaravone Sales Volume by Region (%), (2019-2030)
5.3 Global Edaravone Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Edaravone Sales Value, 2019-2030
5.4.2 North America Edaravone Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Edaravone Sales Value, 2019-2030
5.5.2 Europe Edaravone Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Edaravone Sales Value, 2019-2030
5.6.2 Asia Pacific Edaravone Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Edaravone Sales Value, 2019-2030
5.7.2 South America Edaravone Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Edaravone Sales Value, 2019-2030
5.8.2 Middle East & Africa Edaravone Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Edaravone Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Edaravone Sales Value
6.2.1 Key Countries/Regions Edaravone Sales Value, 2019-2030
6.2.2 Key Countries/Regions Edaravone Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Edaravone Sales Value, 2019-2030
6.3.2 United States Edaravone Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Edaravone Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Edaravone Sales Value, 2019-2030
6.4.2 Europe Edaravone Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Edaravone Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Edaravone Sales Value, 2019-2030
6.5.2 China Edaravone Sales Value by Type (%), 2023 VS 2030
6.5.3 China Edaravone Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Edaravone Sales Value, 2019-2030
6.6.2 Japan Edaravone Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Edaravone Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Edaravone Sales Value, 2019-2030
6.7.2 South Korea Edaravone Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Edaravone Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Edaravone Sales Value, 2019-2030
6.8.2 Southeast Asia Edaravone Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Edaravone Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Edaravone Sales Value, 2019-2030
6.9.2 India Edaravone Sales Value by Type (%), 2023 VS 2030
6.9.3 India Edaravone Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Mitsubishi Tanabe Pharma
7.1.1 Mitsubishi Tanabe Pharma Company Information
7.1.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
7.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Mitsubishi Tanabe Pharma Edaravone Product Offerings
7.1.5 Mitsubishi Tanabe Pharma Recent Development
7.2 Simcere
7.2.1 Simcere Company Information
7.2.2 Simcere Introduction and Business Overview
7.2.3 Simcere Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Simcere Edaravone Product Offerings
7.2.5 Simcere Recent Development
7.3 Taj Pharmaceuticals Ltd.
7.3.1 Taj Pharmaceuticals Ltd. Company Information
7.3.2 Taj Pharmaceuticals Ltd. Introduction and Business Overview
7.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Taj Pharmaceuticals Ltd. Edaravone Product Offerings
7.3.5 Taj Pharmaceuticals Ltd. Recent Development
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Sun Pharmaceutical Industries Ltd. Company Information
7.4.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
7.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Product Offerings
7.4.5 Sun Pharmaceutical Industries Ltd. Recent Development
7.5 Unichem Laboratories Ltd
7.5.1 Unichem Laboratories Ltd Company Information
7.5.2 Unichem Laboratories Ltd Introduction and Business Overview
7.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Unichem Laboratories Ltd Edaravone Product Offerings
7.5.5 Unichem Laboratories Ltd Recent Development
7.6 UCB India Ltd
7.6.1 UCB India Ltd Company Information
7.6.2 UCB India Ltd Introduction and Business Overview
7.6.3 UCB India Ltd Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.6.4 UCB India Ltd Edaravone Product Offerings
7.6.5 UCB India Ltd Recent Development
7.7 Piramal Healthcare
7.7.1 Piramal Healthcare Company Information
7.7.2 Piramal Healthcare Introduction and Business Overview
7.7.3 Piramal Healthcare Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Piramal Healthcare Edaravone Product Offerings
7.7.5 Piramal Healthcare Recent Development
8 Industry Chain Analysis
8.1 Edaravone Industrial Chain
8.2 Edaravone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Edaravone Sales Model
8.5.2 Sales Channel
8.5.3 Edaravone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Edaravone Product Introduction
1.2 Global Edaravone Market Size Forecast
1.2.1 Global Edaravone Sales Value (2019-2030)
1.2.2 Global Edaravone Sales Volume (2019-2030)
1.2.3 Global Edaravone Sales Price (2019-2030)
1.3 Edaravone Market Trends & Drivers
1.3.1 Edaravone Industry Trends
1.3.2 Edaravone Market Drivers & Opportunity
1.3.3 Edaravone Market Challenges
1.3.4 Edaravone Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Edaravone Players Revenue Ranking (2023)
2.2 Global Edaravone Revenue by Company (2019-2024)
2.3 Global Edaravone Players Sales Volume Ranking (2023)
2.4 Global Edaravone Sales Volume by Company Players (2019-2024)
2.5 Global Edaravone Average Price by Company (2019-2024)
2.6 Key Manufacturers Edaravone Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Edaravone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Edaravone
2.9 Edaravone Market Competitive Analysis
2.9.1 Edaravone Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Edaravone Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edaravone as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral Edaravone
3.1.2 Injection Edaravone
3.2 Global Edaravone Sales Value by Type
3.2.1 Global Edaravone Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Edaravone Sales Value, by Type (2019-2030)
3.2.3 Global Edaravone Sales Value, by Type (%) (2019-2030)
3.3 Global Edaravone Sales Volume by Type
3.3.1 Global Edaravone Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Edaravone Sales Volume, by Type (2019-2030)
3.3.3 Global Edaravone Sales Volume, by Type (%) (2019-2030)
3.4 Global Edaravone Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Edaravone Sales Value by Application
4.2.1 Global Edaravone Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Edaravone Sales Value, by Application (2019-2030)
4.2.3 Global Edaravone Sales Value, by Application (%) (2019-2030)
4.3 Global Edaravone Sales Volume by Application
4.3.1 Global Edaravone Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Edaravone Sales Volume, by Application (2019-2030)
4.3.3 Global Edaravone Sales Volume, by Application (%) (2019-2030)
4.4 Global Edaravone Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Edaravone Sales Value by Region
5.1.1 Global Edaravone Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Edaravone Sales Value by Region (2019-2024)
5.1.3 Global Edaravone Sales Value by Region (2025-2030)
5.1.4 Global Edaravone Sales Value by Region (%), (2019-2030)
5.2 Global Edaravone Sales Volume by Region
5.2.1 Global Edaravone Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Edaravone Sales Volume by Region (2019-2024)
5.2.3 Global Edaravone Sales Volume by Region (2025-2030)
5.2.4 Global Edaravone Sales Volume by Region (%), (2019-2030)
5.3 Global Edaravone Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Edaravone Sales Value, 2019-2030
5.4.2 North America Edaravone Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Edaravone Sales Value, 2019-2030
5.5.2 Europe Edaravone Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Edaravone Sales Value, 2019-2030
5.6.2 Asia Pacific Edaravone Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Edaravone Sales Value, 2019-2030
5.7.2 South America Edaravone Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Edaravone Sales Value, 2019-2030
5.8.2 Middle East & Africa Edaravone Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Edaravone Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Edaravone Sales Value
6.2.1 Key Countries/Regions Edaravone Sales Value, 2019-2030
6.2.2 Key Countries/Regions Edaravone Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Edaravone Sales Value, 2019-2030
6.3.2 United States Edaravone Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Edaravone Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Edaravone Sales Value, 2019-2030
6.4.2 Europe Edaravone Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Edaravone Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Edaravone Sales Value, 2019-2030
6.5.2 China Edaravone Sales Value by Type (%), 2023 VS 2030
6.5.3 China Edaravone Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Edaravone Sales Value, 2019-2030
6.6.2 Japan Edaravone Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Edaravone Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Edaravone Sales Value, 2019-2030
6.7.2 South Korea Edaravone Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Edaravone Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Edaravone Sales Value, 2019-2030
6.8.2 Southeast Asia Edaravone Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Edaravone Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Edaravone Sales Value, 2019-2030
6.9.2 India Edaravone Sales Value by Type (%), 2023 VS 2030
6.9.3 India Edaravone Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Mitsubishi Tanabe Pharma
7.1.1 Mitsubishi Tanabe Pharma Company Information
7.1.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
7.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Mitsubishi Tanabe Pharma Edaravone Product Offerings
7.1.5 Mitsubishi Tanabe Pharma Recent Development
7.2 Simcere
7.2.1 Simcere Company Information
7.2.2 Simcere Introduction and Business Overview
7.2.3 Simcere Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Simcere Edaravone Product Offerings
7.2.5 Simcere Recent Development
7.3 Taj Pharmaceuticals Ltd.
7.3.1 Taj Pharmaceuticals Ltd. Company Information
7.3.2 Taj Pharmaceuticals Ltd. Introduction and Business Overview
7.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Taj Pharmaceuticals Ltd. Edaravone Product Offerings
7.3.5 Taj Pharmaceuticals Ltd. Recent Development
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Sun Pharmaceutical Industries Ltd. Company Information
7.4.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
7.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Product Offerings
7.4.5 Sun Pharmaceutical Industries Ltd. Recent Development
7.5 Unichem Laboratories Ltd
7.5.1 Unichem Laboratories Ltd Company Information
7.5.2 Unichem Laboratories Ltd Introduction and Business Overview
7.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Unichem Laboratories Ltd Edaravone Product Offerings
7.5.5 Unichem Laboratories Ltd Recent Development
7.6 UCB India Ltd
7.6.1 UCB India Ltd Company Information
7.6.2 UCB India Ltd Introduction and Business Overview
7.6.3 UCB India Ltd Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.6.4 UCB India Ltd Edaravone Product Offerings
7.6.5 UCB India Ltd Recent Development
7.7 Piramal Healthcare
7.7.1 Piramal Healthcare Company Information
7.7.2 Piramal Healthcare Introduction and Business Overview
7.7.3 Piramal Healthcare Edaravone Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Piramal Healthcare Edaravone Product Offerings
7.7.5 Piramal Healthcare Recent Development
8 Industry Chain Analysis
8.1 Edaravone Industrial Chain
8.2 Edaravone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Edaravone Sales Model
8.5.2 Sales Channel
8.5.3 Edaravone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Edaravone Market Trends
Table 2. Edaravone Market Drivers & Opportunity
Table 3. Edaravone Market Challenges
Table 4. Edaravone Market Restraints
Table 5. Global Edaravone Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Edaravone Revenue Market Share by Company (2019-2024)
Table 7. Global Edaravone Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Edaravone Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Edaravone Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Edaravone Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Edaravone Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Edaravone
Table 13. Global Edaravone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edaravone as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Edaravone Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Edaravone Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Edaravone Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Edaravone Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Edaravone Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Edaravone Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Edaravone Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Edaravone Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Edaravone Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Edaravone Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Edaravone Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Edaravone Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Edaravone Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Edaravone Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Edaravone Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Edaravone Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Edaravone Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Edaravone Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Edaravone Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Edaravone Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Edaravone Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Edaravone Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Edaravone Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Edaravone Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Edaravone Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Edaravone Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Edaravone Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Edaravone Sales Value by Region (2019-2024) & (%)
Table 44. Global Edaravone Sales Value by Region (2025-2030) & (%)
Table 45. Global Edaravone Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Edaravone Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Edaravone Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Edaravone Sales Volume by Region (2019-2024) & (%)
Table 49. Global Edaravone Sales Volume by Region (2025-2030) & (%)
Table 50. Global Edaravone Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Edaravone Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Edaravone Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Edaravone Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Edaravone Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Edaravone Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Edaravone Sales Volume, (2025-2030) & (K Units)
Table 57. Mitsubishi Tanabe Pharma Company Information
Table 58. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 59. Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Mitsubishi Tanabe Pharma Edaravone Product Offerings
Table 61. Mitsubishi Tanabe Pharma Recent Development
Table 62. Simcere Company Information
Table 63. Simcere Introduction and Business Overview
Table 64. Simcere Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Simcere Edaravone Product Offerings
Table 66. Simcere Recent Development
Table 67. Taj Pharmaceuticals Ltd. Company Information
Table 68. Taj Pharmaceuticals Ltd. Introduction and Business Overview
Table 69. Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Taj Pharmaceuticals Ltd. Edaravone Product Offerings
Table 71. Taj Pharmaceuticals Ltd. Recent Development
Table 72. Sun Pharmaceutical Industries Ltd. Company Information
Table 73. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 74. Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Sun Pharmaceutical Industries Ltd. Edaravone Product Offerings
Table 76. Sun Pharmaceutical Industries Ltd. Recent Development
Table 77. Unichem Laboratories Ltd Company Information
Table 78. Unichem Laboratories Ltd Introduction and Business Overview
Table 79. Unichem Laboratories Ltd Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Unichem Laboratories Ltd Edaravone Product Offerings
Table 81. Unichem Laboratories Ltd Recent Development
Table 82. UCB India Ltd Company Information
Table 83. UCB India Ltd Introduction and Business Overview
Table 84. UCB India Ltd Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. UCB India Ltd Edaravone Product Offerings
Table 86. UCB India Ltd Recent Development
Table 87. Piramal Healthcare Company Information
Table 88. Piramal Healthcare Introduction and Business Overview
Table 89. Piramal Healthcare Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Piramal Healthcare Edaravone Product Offerings
Table 91. Piramal Healthcare Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Edaravone Downstream Customers
Table 95. Edaravone Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Edaravone Product Picture
Figure 2. Global Edaravone Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Edaravone Sales Volume (2019-2030) & (K Units)
Figure 5. Global Edaravone Sales Price (2019-2030) & (USD/Unit)
Figure 6. Edaravone Report Years Considered
Figure 7. Global Edaravone Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Edaravone Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Edaravone Revenue in 2023
Figure 10. Edaravone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Edaravone Picture
Figure 12. Injection Edaravone Picture
Figure 13. Global Edaravone Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Edaravone Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Edaravone Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Edaravone Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Edaravone Price by Type (2019-2030) & (USD/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Edaravone Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Edaravone Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Edaravone Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Edaravone Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Edaravone Price by Application (2019-2030) & (USD/Unit)
Figure 26. North America Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Edaravone Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Edaravone Sales Volume (%), (2019-2030)
Figure 38. United States Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 44. China Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 46. China Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 56. India Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 58. India Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 59. Edaravone Industrial Chain
Figure 60. Edaravone Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Edaravone Market Trends
Table 2. Edaravone Market Drivers & Opportunity
Table 3. Edaravone Market Challenges
Table 4. Edaravone Market Restraints
Table 5. Global Edaravone Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Edaravone Revenue Market Share by Company (2019-2024)
Table 7. Global Edaravone Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Edaravone Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Edaravone Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Edaravone Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Edaravone Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Edaravone
Table 13. Global Edaravone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edaravone as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Edaravone Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Edaravone Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Edaravone Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Edaravone Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Edaravone Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Edaravone Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Edaravone Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Edaravone Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Edaravone Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Edaravone Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Edaravone Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Edaravone Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Edaravone Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Edaravone Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Edaravone Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Edaravone Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Edaravone Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Edaravone Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Edaravone Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Edaravone Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Edaravone Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Edaravone Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Edaravone Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Edaravone Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Edaravone Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Edaravone Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Edaravone Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Edaravone Sales Value by Region (2019-2024) & (%)
Table 44. Global Edaravone Sales Value by Region (2025-2030) & (%)
Table 45. Global Edaravone Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Edaravone Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Edaravone Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Edaravone Sales Volume by Region (2019-2024) & (%)
Table 49. Global Edaravone Sales Volume by Region (2025-2030) & (%)
Table 50. Global Edaravone Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Edaravone Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Edaravone Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Edaravone Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Edaravone Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Edaravone Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Edaravone Sales Volume, (2025-2030) & (K Units)
Table 57. Mitsubishi Tanabe Pharma Company Information
Table 58. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 59. Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Mitsubishi Tanabe Pharma Edaravone Product Offerings
Table 61. Mitsubishi Tanabe Pharma Recent Development
Table 62. Simcere Company Information
Table 63. Simcere Introduction and Business Overview
Table 64. Simcere Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Simcere Edaravone Product Offerings
Table 66. Simcere Recent Development
Table 67. Taj Pharmaceuticals Ltd. Company Information
Table 68. Taj Pharmaceuticals Ltd. Introduction and Business Overview
Table 69. Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Taj Pharmaceuticals Ltd. Edaravone Product Offerings
Table 71. Taj Pharmaceuticals Ltd. Recent Development
Table 72. Sun Pharmaceutical Industries Ltd. Company Information
Table 73. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 74. Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Sun Pharmaceutical Industries Ltd. Edaravone Product Offerings
Table 76. Sun Pharmaceutical Industries Ltd. Recent Development
Table 77. Unichem Laboratories Ltd Company Information
Table 78. Unichem Laboratories Ltd Introduction and Business Overview
Table 79. Unichem Laboratories Ltd Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Unichem Laboratories Ltd Edaravone Product Offerings
Table 81. Unichem Laboratories Ltd Recent Development
Table 82. UCB India Ltd Company Information
Table 83. UCB India Ltd Introduction and Business Overview
Table 84. UCB India Ltd Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. UCB India Ltd Edaravone Product Offerings
Table 86. UCB India Ltd Recent Development
Table 87. Piramal Healthcare Company Information
Table 88. Piramal Healthcare Introduction and Business Overview
Table 89. Piramal Healthcare Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Piramal Healthcare Edaravone Product Offerings
Table 91. Piramal Healthcare Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Edaravone Downstream Customers
Table 95. Edaravone Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Edaravone Product Picture
Figure 2. Global Edaravone Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Edaravone Sales Volume (2019-2030) & (K Units)
Figure 5. Global Edaravone Sales Price (2019-2030) & (USD/Unit)
Figure 6. Edaravone Report Years Considered
Figure 7. Global Edaravone Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Edaravone Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Edaravone Revenue in 2023
Figure 10. Edaravone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Edaravone Picture
Figure 12. Injection Edaravone Picture
Figure 13. Global Edaravone Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Edaravone Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Edaravone Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Edaravone Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Edaravone Price by Type (2019-2030) & (USD/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Edaravone Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Edaravone Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Edaravone Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Edaravone Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Edaravone Price by Application (2019-2030) & (USD/Unit)
Figure 26. North America Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Edaravone Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Edaravone Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Edaravone Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Edaravone Sales Volume (%), (2019-2030)
Figure 38. United States Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 44. China Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 46. China Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 56. India Edaravone Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Edaravone Sales Value by Type (%), 2023 VS 2030
Figure 58. India Edaravone Sales Value by Application (%), 2023 VS 2030
Figure 59. Edaravone Industrial Chain
Figure 60. Edaravone Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232